Literature DB >> 22890298

Sexual medicine: Why stop a good thing? Discontinuing PDE5 inhibitors.

Helen M Conaglen, John V Conaglen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22890298     DOI： 10.1038/nrurol.2012.165

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation.

Authors:  Ana A Carvalheira; Nuno Monteiro Pereira; João Maroco; Vera Forjaz
Journal:  J Sex Med       Date:  2012-05-22       Impact factor: 3.802

Review 2.  A 4-year update on the safety of sildenafil citrate (Viagra).

Authors:  Harin Padma-nathan; Ian Eardley; Robert A Kloner; Alan M Laties; Francesco Montorsi
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

3.  Female partner perception of Small-Carrion implant.

Authors:  S Kramarsky-Binkhorst
Journal:  Urology       Date:  1978-11       Impact factor: 2.649

4.  Couples' reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12 to 24-month follow-up after a 6-month free trial.

Authors:  Helen M Conaglen; John V Conaglen
Journal:  J Sex Med       Date:  2012-01-12       Impact factor: 3.802

5.  The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2007 May-Jun       Impact factor: 2.953

Review 6.  When an erection alone is not enough: biopsychosocial obstacles to lovemaking.

Authors:  S E Althof
Journal:  Int J Impot Res       Date:  2002-02       Impact factor: 2.896

7.  How long do patients with erectile dysfunction continue to use sildenafil citrate? Dropout rate from treatment course as outcome in real life.

Authors:  Yoshikazu Sato; Hitoshi Tanda; Shuji Kato; Shigeki Onishi; Toshikazu Nitta; Mikio Koroku
Journal:  Int J Urol       Date:  2007-04       Impact factor: 3.369

Review 8.  Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatment.

Authors:  T F Al-Shaiji; G B Brock
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Why do so many people drop out from auto-injection therapy for impotence?

Authors:  S E Althof; L A Turner; S B Levine; C Risen; E Kursh; D Bodner; M Resnick
Journal:  J Sex Marital Ther       Date:  1989

10.  Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction.

Authors:  Konstantinos Giannitsas; Angelis Konstantinopoulos; Christos Patsialas; Petros Perimenis
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.